Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Should hypercholesterolemic women be treated?].

J Emmerich1, F Delahaye, E Bruckert

  • 1Service de pathologie vasculaire, Hôpital Broussais, Paris.

Archives Des Maladies Du Coeur Et Des Vaisseaux
|October 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Team nursing.

Nursing times·1992
Same author

Lack of platelet-activating factor release during reversible myocardial ischaemia.

European heart journal·1992
Same author

[Diagnostic and therapeutic strategy in patients with multiple arterial disease].

Annales de cardiologie et d'angeiologie·1992
Same author

Risk assessment for aflatoxin B1: a modeling approach.

Risk analysis : an official publication of the Society for Risk Analysis·1992
Same author

Comparison of skin changes induced on mice by either group A type 12 or group G streptococci.

Experimental dermatology·1992
Same author

IBIS integrated biological imaging system: electron micrograph image-processing software running on Unix workstations.

Computer applications in the biosciences : CABIOS·1992

Cardiovascular disease is a leading cause of death for women. Early treatment for high cholesterol is advised when levels exceed 3 g/l, especially considering low HDL-cholesterol.

Area of Science:

  • Cardiology
  • Endocrinology
  • Public Health

Context:

  • Cardiovascular disease (CVD) is the primary cause of mortality in women, mirroring men.
  • Hypercholesterolaemia presents a significant risk factor for CVD in women, though risk thresholds differ from men.
  • Limited research exists on hypercholesterolaemia management specifically in women.

Purpose:

  • To highlight the understudied issue of hypercholesterolaemia in women.
  • To identify key lipid parameters (low HDL-cholesterol, high triglycerides) predictive of coronary events in women.
  • To underscore the need for dedicated trials on lipid-lowering therapies for women.

Summary:

  • Serum cholesterol is a risk factor for cardiovascular events in women, with increased risk observed at higher cholesterol values compared to men.

Related Experiment Videos

  • Low high-density lipoprotein (HDL)-cholesterol is a strong predictor of coronary events in women, particularly when accompanied by elevated triglycerides.
  • While hormone replacement therapy shows potential cardiovascular benefits, the efficacy of treating mild hypercholesterolaemia in women remains unproven. Early intervention is recommended for serum cholesterol levels above 3 g/l (7.77 mmol/l).

    • Impact:

    • Informs clinical practice regarding cholesterol management in women.
    • Identifies critical areas for future research in women's cardiovascular health.
    • Emphasizes the importance of personalized risk assessment for hypercholesterolaemia in the female population.